Comments on: CD-388 by Cidara Therapeutics for Influenzavirus B Infections: Likelihood of Approval /data-insights/cd-388-cidara-therapeutics-influenzavirus-b-infections-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Wed, 19 Jun 2024 01:36:10 +0000 hourly 1 https://wordpress.org/?v=6.6.2